Topical treatment with the Toll-like receptor agonist DIMS0150 has potential for lasting relief of symptoms in patients with chronic active ulcerative colitis by restoring glucocorticoid sensitivity.

Topical treatment with the Toll-like receptor agonist DIMS0150 has potential for lasting relief of symptoms in patients with chronic active ulcerative colitis by restoring glucocorticoid sensitivity.

Item
http://www.wikidata.org/entity/Q39247690
Epithelial toll-like receptor 9 signaling in colorectal inflammation and cancer: clinico-pathogenic aspectsBiomarkers can predict potential clinical responders to DIMS0150 a toll-like receptor 9 agonist in ulcerative colitis patients.Clinical Effects of a Topically Applied Toll-like Receptor 9 Agonist in Active Moderate-to-Severe Ulcerative Colitis.Toll-like receptor agonists: a patent review (2011 - 2013).Immunomodulatory oligonucleotides inhibit neutrophil migration by decreasing the surface expression of interleukin-8 and leukotriene B4 receptors.Nucleic acid-sensing TLRs and autoimmunity: novel insights from structural and cell biology.Type 1 Interferon in the Human Intestine-A Co-ordinator of the Immune Response to the Microbiota.Endoscopic Mucosal Healing Predicts Favorable Clinical Outcomes in Inflammatory Bowel Disease: A Meta-analysis.Regulation of human intestinal T-cell responses by type 1 interferon-STAT1 signaling is disrupted in inflammatory bowel disease.TLR Agonists as Adjuvants for Cancer Vaccines.Ameliorating Active Ulcerative Colitis via an Orally Available Toll-Like Receptor-9 Modifier: A Prospective Open-Label, Multicenter Phase II Trial.TLR9 regulates adipose tissue inflammation and obesity-related metabolic disorders.Emerging Mechanisms of Innate Immunity and Their Translational Potential in Inflammatory Bowel Disease.Emerging Therapies for Inflammatory Bowel Disease
P2860

Topical treatment with the Toll-like receptor agonist DIMS0150 has potential for lasting relief of symptoms in patients with chronic active ulcerative colitis by restoring glucocorticoid sensitivity.

Item
http://www.wikidata.org/entity/Q39247690
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Topical treatment with the Tol ...... ng glucocorticoid sensitivity.
@en
Topical treatment with the Tol ...... ng glucocorticoid sensitivity.
@nl
type
label
Topical treatment with the Tol ...... ng glucocorticoid sensitivity.
@en
Topical treatment with the Tol ...... ng glucocorticoid sensitivity.
@nl
prefLabel
Topical treatment with the Tol ...... ng glucocorticoid sensitivity.
@en
Topical treatment with the Tol ...... ng glucocorticoid sensitivity.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P356
P1433
P1476
Topical treatment with the Tol ...... ng glucocorticoid sensitivity.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921